These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16455347)

  • 1. 7. Control of allergic airway inflammation through immunomodulation.
    Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S461-4. PubMed ID: 16455347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of suplatast tosilate on eosinophil migration].
    Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
    Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in suplatast tosilate research.
    Sano Y; Yamada H
    Clin Exp Allergy; 2007 Jul; 37(7):970-2. PubMed ID: 17581190
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of suplatast tosilate on antileukotriene non-responders with mild-to-moderate persistent asthma.
    Wada M; Nagata S; Kudo T; Shimizu T; Yamashiro Y
    Allergol Int; 2009 Sep; 58(3):389-93. PubMed ID: 19542765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cough-variant asthma successfully treated with suplatast tosilate].
    Fujimori K; Suzuki E; Arakawa M
    Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
    Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
    J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
    J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer therapies for asthma: a focus on anti-IgE.
    Babu KS; Holgate ST
    Indian J Chest Dis Allied Sci; 2002; 44(2):107-15. PubMed ID: 12026249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
    J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
    Nagakura T; Ogino S; Okubo K; Sato N; Takahashi M; Ishikawa T
    Clin Exp Allergy; 2008 Feb; 38(2):329-37. PubMed ID: 18070163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
    Yamasawa H; Oshikawa K; Sugiyama Y
    Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
    Hashizume H; Umayahara T
    Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
    Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.